XO Life funding news – Munich-based XO Life Secures €7 Million in Funding
Aug 22, 2024 | By Team SR
XO Life, a leading digital health startup, has developed the ImpactMonitor™ platform, a meta-platform that provides patients with trustworthy health information, therapy monitoring as well as support and exchange with other patients.
SUMMARY
- The Munich-based business declared that it has raised €7 million to fuel the global expansion of its platform.
- XO Life has created a globally unique meta-platform, the ImpactMonitor™ platform, for digital product and therapy support for patients.
The Munich-based business declared that it has raised €7 million to fuel the global expansion of its platform. A tailored substitute for common searches on sites like Google, Facebook, Instagram, or TikTok is ImpactMonitorTM.
Read also - Gaussion funding news – London-based Gaussion Raises $12 Million in Series A Round Funding
Vi Partners and Bayern Kapital are among the round's participants, with Sandwater and Grazia Equity acting as the lead investors. Returning participants include Aescuvest, Winning Mindset Ventures, and Isartal Ventures.
RECOMMENDED FOR YOU
QMill funding news – Finland-based QMill Secures €4 Million in Seed Funding
Team SR
Sep 17, 2024
Dr. Friderike Bruchmann, Co-Founder and CEO of XO Life said, “This investment will enable us to advance our technology and expand internationally. Having proven our success in the German market, we are eager to address global health challenges and bring our innovative solutions to a wider audience,”
When a patient is given a diagnosis or prescription, they have a major need for communication and information. At least once a week, 70% of patients conduct internet research, with Google and Facebook being their first choices.1. On the other hand, user searches for advertisements and search engine optimization are commonplace in online content. Because of this, only 8 out of 10 patients trust information found online, making them feel insecure and alone.
Morten E. Iversen, Partner at Sandwater, explained: “We are enthusiastic about the unique opportunities and possibilities of XO Life’s meta-platform. We are convinced that the ImpactMonitor™ platform will fill an important gap in healthcare by providing comprehensive health information and patient support across Europe and beyond.”
Jochen Klüppel, Partner at Grazia Equity, emphasised: “XO Life has developed and built an impressive digital meta-platform. Backed by a strong VC consortium, the team, which has technical expertise in medicine, natural sciences and information technology and brings together talent from more than 13 nations, can take the ImpactMonitor™ platform to the next level. We are relying on the best of the best to revolutionize an entire industry!”
About XO Life
XO Life has created a globally unique meta-platform, the ImpactMonitor™ platform, for digital product and therapy support for patients. Patients are accompanied during their product application or therapy with verified medical and health-related content, record their health and therapy progress, receive personalized insights and medical support from experts, and can exchange information with other patients.